Trials / Recruiting
RecruitingNCT06263998
Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops
A Randomized, Double-blind, Parallel, Placebo-Controlled, Single and Multiple Ascending Dose Phase 1 Clinical Study to Assess the Safety, and Local Tolerance, Pharmacokinetics After Application of NCP112 Eye Drop in Healthy Subjects
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Huons Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The objective is to evaluate the safety, local tolerability, and pharmacokinetics of NCP112 eye drops through single and multiple dose-escalation ocular administrations in healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NCP112 | NCP112 topical ophthalmic solution |
| DRUG | NCP112 Placebo | Placebo comparator |
Timeline
- Start date
- 2024-07-11
- Primary completion
- 2025-11-28
- Completion
- 2026-01-30
- First posted
- 2024-02-16
- Last updated
- 2024-10-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06263998. Inclusion in this directory is not an endorsement.